This trial is testing a combination of drugs to treat patients who have had surgery for stage II colon cancer, to see if it is more effective than a standard combination of drugs.
1 Primary · 3 Secondary · Reporting Duration: Up to 10 years
3610 Total Participants · 3 Treatment Groups
Primary Treatment: Fluorouracil · No Placebo Group · Phase 3
Age 18+ · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
|18 - 65||100.0%|
|Duke Raleigh Hospital||100.0%|